THE USE OF AN LH-RH AGONIST (ICI 118630, ZOLADEX) IN ADVANCED PREMENOPAUSAL BREAST-CANCER

被引:100
作者
WILLIAMS, MR [1 ]
WALKER, KJ [1 ]
TURKES, A [1 ]
BLAMEY, RW [1 ]
NICHOLSON, RI [1 ]
机构
[1] UNIV WALES COLL MED,TENOVUS INST CANC RES,CARDIFF CF4 4XX,S GLAM,WALES
关键词
D O I
10.1038/bjc.1986.106
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:629 / 636
页数:8
相关论文
共 9 条
[1]  
CORBIN A, 1982, YALE J BIOL MED, V55, P27
[2]  
HARVEY HA, 1981, P AM ASSOC CANC RES, V22, P444
[3]  
HAYWARD JL, 1977, CANCER, V39, P1289, DOI 10.1002/1097-0142(197703)39:3<1289::AID-CNCR2820390340>3.0.CO
[4]  
2-F
[5]  
KENNEDY BJ, 1964, SURG GYNECOL OBSTET, V118, P524
[6]  
KLIJN JGM, 1984, MED ONCOL TUMOR PHAR, V1, P123
[7]   EFFECTS OF HIGH-DOSES OF A SERIES OF NEW LUTEINIZING-HORMONE-RELEASING HORMONE ANALOGS IN INTACT FEMALE RATS [J].
MAYNARD, PV ;
NICHOLSON, RI .
BRITISH JOURNAL OF CANCER, 1979, 39 (03) :274-279
[8]   ANTI-TUMOUR ACTIVITY OF ICI 11863-NEW POTENT LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST [J].
NICHOLSON, RI ;
MAYNARD, PV .
BRITISH JOURNAL OF CANCER, 1979, 39 (03) :268-273
[9]  
1974, LANCET, V2, P38